Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Genesis Research Group

    Website
    Email
    +1 888 503 2680

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise, and a revolutionary engagement model, they enable pharmaceutical, biotech, and medical device companies to anticipate and address the evolving evidence needs of payers, regulators, and stakeholders.

    The company’s tailored solutions encompass strategic guidance and scientifically rigorous real-world evidence, health economics and outcomes research, and market access solutions. With a vision to redefine healthcare research, they accelerate patient access to optimal care through unique insights and agile, technology-enabled research partnerships.

    Powered by an innovative FIT engagement model, Genesis Research Group delivers dedicated, cross-functional teams that seamlessly integrate with client organizations and pivot quickly to meet changing research needs.

    For more information, visit www.genesisrg.com

    111 River Street, Suite 1120, Hoboken, NJ, 07030, United States

    End-to-end intergrated evidence planning and value demonstration

    EVIDENCE STRATEGY

    • HEOR and RWE Strategic Planning
    • Value Proposition Development & Testing
    • Stakeholder Advisory Boards & Payer Panels
    • Scientific Advice
    • HTA / ICER Support
    • Access and Pricing
    • Stakeholder Insights (RPR)

    EVIDENCE GENERATION

    • Claims & EHR Database Analyses
    • External Control Arms
    • Meta-Analyses & Indirect Treatment Comparisons
    • Targeted & Systematic Literature Reviews
    • Economic Modeling
    • Outcomes-based Contracting

    EVIDENCE OPTIMIZATION

    • EVID AI: Technology-assisted evidence synthesis
    • Technology-Assisted Literature Reviews
    • Interactive RWE Dashboards
    • Evidence Management Platforms
    • RWE Automation

    EVIDENCE COMMUNICATION

    • Value Dossiers
    • Manuscripts, Abstracts, and Posters
    • Evidence Slide Decks for MSL & Commercial Teams
    • HTA Automation

    Tim Wright Updates ISPOR Europe MFN Pricing Presentation in New Interview

    At ISPOR Europe in Glasgow, there were literal queues around the block for Tim Wright's HEOR Theater presentation 'MFN Pricing: More Fun to Navigate – A European Roadmap to Success,' with potentially...

    Genesis Research Group contributes strong scientific program to ISPOR Europe and warmly invites visitors to booth 212

    Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific program that includes an HEOR Theater session, contributions to 10...

    ISPOR hosts expert webinar exploring the value of ECAs for regulatory and HTA evidence needs

    On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...

    Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

    HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

    Genesis Research Group Appoints Tim Wright as Executive Vice President, Access and Pricing

    Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the appointment of Tim Wright as Executive Vice...

    Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.

    In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group's recent expansion of its real-world data...

    Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

    Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural...

    Genesis Research Group survey discovers how payers are responding to Maximum Fair Prices (MFPs) under the Inflation Reduction Act

    To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business approaches, Genesis Research Group employed their RPR stakeholder engagement platform and vetted stakeholder network to...

    Genesis Research Group ISPOR Europe presentation ‘Planning with Insights: Even the Best Economic Models Need Validation’ features in scientific publication

    We are pleased to share that The Evidence Base have carried out a 'deep dive' into a Genesis Research Group presentation on economic modeling in healthcare and harnessing stakeholder insights...

    Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online

    Genesis Research Group's poster 'Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey' was recently named as...

    ALL PRESS RELEASES

    Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group

    A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition...

    Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway (OCP) developers

    Based on insights from 15 U.S. payers and providers, this white paper explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers.

    ALL WHITE PAPERS

    Navigating US market access analytics: A conversation with Ki Park

    In the rapidly evolving landscape of healthcare and pharmaceutical market access, data analytics has become a critical component for making informed decisions. We sat down with Ki Park, our Vice...

    Alice Beer of ITN Business recently interviewed David W. Miller, CEO of Genesis Research Group, on ‘Advancing Healthcare’

    ITN Business invited Genesis Research Group to contribute to a news style programme 'Advancing Healthcare' featuring key opinion leaders in the healthcare sector. Our CEO David W. Miller was one...

    How does Genesis Research Group ‘Innovate differently’?

    New Genesis Research Group CEO David W. Miller explains what we mean when we say we help our life science clients to 'Innovate differently' and transform the way they engage...

    Envision Analogue – An Introduction

    Powered by primary payer market research, Envision is an online platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive...

    World EPA Congress 2024: ‘Shining the light on vaccine market access’ by Genesis Research Group

    A presentation with Katrin Nather, PhD, Associate Director, and Tijana Ignjatovic, Executive Director, Genesis Research Group. Contact solutions@genesisrg.com or visit www.genesisrg.com. With more and more innovative vaccines and immunization strategies...

    Fit-for-purpose matchmaking webinar: a data selection and RWE approach for both regulatory and HTA audiences

    This webinar reviews considerations for the design and data selection for RWE studies, including external control arm studies, to meet regulatory and HTA needs. Regulators and agencies responsible for market...

    ISPOR 2023: Developing Fit-for-Purpose External Control Arms to Optimize Submissions to Regulatory and Health Technology Assessment Agencies

    RPR: an agile, on-demand platform that provides clients with faster, higher-quality insights via direct, automated stakeholder engagement.

    Accelerating Generation of Payer Insights & Evidence Across the Lifecycle to Achieve Optimal Access

    ISPOR Europe: Generating Payer Insights & Evidence: Meeting the Challenges of New Evidence Paradigm

    ALL VIDEOS AND PODCASTS

    Carolyn Hillegass

    Carolyn Hillegass
    Chief Commercial Officer
    solutions@genesisrg.com
    Linkedin Profile

    David W. Miller

    David W. Miller
    Chairman & Chief Executive Officer
    solutions@genesisrg.com
    Linkedin Profile

    Lynn Okamoto

    Lynn Okamoto
    Chief Business Officer
    solutions@genesisrg.com
    Linkedin Profile

    “We are really impressed with the efficiency and quality of the work, your leadership skills, and the extra efforts you’ve made to ensure the results are absolutely accurate.”

    HEOR / RWE client

    Company Details

    Genesis Research Group logo

    Email
    Website

     Latest Content from  Genesis Research Group 

    Tim Wright Updates ISPOR Europe MFN Pricing Presentation in New Interview

    At ISPOR Europe in Glasgow, there were literal queues around the block for Tim Wright's HEOR Theater presentation 'MFN Pricing: More Fun to Navigate – A European Roadmap to Success,' with potentially...

    Genesis Research Group contributes strong scientific program to ISPOR Europe and warmly invites visitors to booth 212

    Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific program that includes an HEOR Theater session, contributions to 10...

    ISPOR hosts expert webinar exploring the value of ECAs for regulatory and HTA evidence needs

    On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...

    Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

    HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

    Genesis Research Group Appoints Tim Wright as Executive Vice President, Access and Pricing

    Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the appointment of Tim Wright as Executive Vice...

    Navigating US market access analytics: A conversation with Ki Park

    In the rapidly evolving landscape of healthcare and pharmaceutical market access, data analytics has become a critical component for making informed decisions. We sat down with Ki Park, our Vice...

    Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.

    In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group's recent expansion of its real-world data...

    Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

    Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural...

    Genesis Research Group survey discovers how payers are responding to Maximum Fair Prices (MFPs) under the Inflation Reduction Act

    To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business approaches, Genesis Research Group employed their RPR stakeholder engagement platform and vetted stakeholder network to...

    Genesis Research Group ISPOR Europe presentation ‘Planning with Insights: Even the Best Economic Models Need Validation’ features in scientific publication

    We are pleased to share that The Evidence Base have carried out a 'deep dive' into a Genesis Research Group presentation on economic modeling in healthcare and harnessing stakeholder insights...